ラクオリア創薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/30 | 1,399 | 1,407 | 1,390 | 1,405 | +6 | +0.4% | 142,700 |
2019/07/29 | 1,423 | 1,423 | 1,395 | 1,399 | -6 | -0.4% | 135,600 |
2019/07/26 | 1,403 | 1,423 | 1,400 | 1,405 | -12 | -0.8% | 134,600 |
2019/07/25 | 1,406 | 1,421 | 1,398 | 1,417 | +4 | +0.3% | 186,300 |
2019/07/24 | 1,450 | 1,459 | 1,410 | 1,413 | -20 | -1.4% | 386,600 |
2019/07/23 | 1,420 | 1,433 | 1,407 | 1,433 | +11 | +0.8% | 139,900 |
2019/07/22 | 1,436 | 1,441 | 1,415 | 1,422 | -27 | -1.9% | 215,500 |
2019/07/19 | 1,403 | 1,457 | 1,400 | 1,449 | +53 | +3.8% | 405,600 |
2019/07/18 | 1,439 | 1,440 | 1,381 | 1,396 | -55 | -3.8% | 443,600 |
2019/07/17 | 1,476 | 1,481 | 1,431 | 1,451 | -29 | -2% | 344,500 |
2019/07/16 | 1,472 | 1,481 | 1,454 | 1,480 | +28 | +1.9% | 366,400 |
2019/07/12 | 1,495 | 1,499 | 1,451 | 1,452 | -47 | -3.1% | 347,200 |
2019/07/11 | 1,498 | 1,510 | 1,482 | 1,499 | +12 | +0.8% | 291,700 |
2019/07/10 | 1,470 | 1,515 | 1,462 | 1,487 | +27 | +1.8% | 575,400 |
2019/07/09 | 1,458 | 1,470 | 1,435 | 1,460 | +3 | +0.2% | 320,200 |
2019/07/08 | 1,490 | 1,505 | 1,446 | 1,457 | -30 | -2% | 514,800 |
2019/07/05 | 1,439 | 1,489 | 1,435 | 1,487 | +46 | +3.2% | 514,100 |
2019/07/04 | 1,435 | 1,446 | 1,408 | 1,441 | +17 | +1.2% | 419,700 |
2019/07/03 | 1,453 | 1,468 | 1,394 | 1,424 | -40 | -2.7% | 680,800 |
2019/07/02 | 1,474 | 1,510 | 1,435 | 1,464 | +50 | +3.5% | 1,110,300 |
2019/07/01 | 1,407 | 1,435 | 1,395 | 1,414 | +14 | +1% | 378,000 |
2019/06/28 | 1,390 | 1,420 | 1,373 | 1,400 | +7 | +0.5% | 448,700 |
2019/06/27 | 1,360 | 1,475 | 1,355 | 1,393 | +23 | +1.7% | 733,600 |
2019/06/26 | 1,356 | 1,377 | 1,339 | 1,370 | +14 | +1% | 206,900 |
2019/06/25 | 1,366 | 1,386 | 1,344 | 1,356 | -2 | -0.1% | 347,200 |
2019/06/24 | 1,348 | 1,377 | 1,343 | 1,358 | -11 | -0.8% | 228,500 |
2019/06/21 | 1,402 | 1,404 | 1,365 | 1,369 | -33 | -2.4% | 257,700 |
2019/06/20 | 1,380 | 1,412 | 1,361 | 1,402 | +33 | +2.4% | 335,400 |
2019/06/19 | 1,350 | 1,370 | 1,335 | 1,369 | +51 | +3.9% | 345,900 |
2019/06/18 | 1,358 | 1,374 | 1,311 | 1,318 | -50 | -3.7% | 578,800 |
2019/06/17 | 1,394 | 1,410 | 1,358 | 1,368 | -33 | -2.4% | 280,100 |
2019/06/14 | 1,350 | 1,409 | 1,350 | 1,401 | +34 | +2.5% | 491,900 |
2019/06/13 | 1,411 | 1,418 | 1,367 | 1,367 | -61 | -4.3% | 502,800 |
2019/06/12 | 1,462 | 1,478 | 1,425 | 1,428 | -42 | -2.9% | 420,800 |
2019/06/11 | 1,499 | 1,502 | 1,466 | 1,470 | -26 | -1.7% | 324,800 |
2019/06/10 | 1,495 | 1,541 | 1,485 | 1,496 | -8 | -0.5% | 413,300 |
2019/06/07 | 1,516 | 1,532 | 1,498 | 1,504 | -2 | -0.1% | 278,900 |
2019/06/06 | 1,508 | 1,532 | 1,495 | 1,506 | -9 | -0.6% | 243,200 |
2019/06/05 | 1,541 | 1,558 | 1,501 | 1,515 | -2 | -0.1% | 533,600 |
2019/06/04 | 1,456 | 1,517 | 1,456 | 1,517 | +55 | +3.8% | 271,600 |
2019/06/03 | 1,495 | 1,531 | 1,453 | 1,462 | -67 | -4.4% | 572,200 |
2019/05/31 | 1,529 | 1,544 | 1,507 | 1,529 | +4 | +0.3% | 292,400 |
2019/05/30 | 1,561 | 1,562 | 1,500 | 1,525 | -42 | -2.7% | 638,900 |
2019/05/29 | 1,595 | 1,602 | 1,559 | 1,567 | -61 | -3.7% | 498,800 |
2019/05/28 | 1,565 | 1,632 | 1,553 | 1,628 | +60 | +3.8% | 618,200 |
2019/05/27 | 1,567 | 1,584 | 1,547 | 1,568 | -4 | -0.3% | 282,500 |
2019/05/24 | 1,582 | 1,607 | 1,561 | 1,572 | -44 | -2.7% | 506,200 |
2019/05/23 | 1,590 | 1,627 | 1,565 | 1,616 | +10 | +0.6% | 584,300 |
2019/05/22 | 1,583 | 1,606 | 1,561 | 1,606 | +24 | +1.5% | 450,800 |
2019/05/21 | 1,526 | 1,587 | 1,522 | 1,582 | +39 | +2.5% | 409,500 |
1301~
1350
件表示中 / 3268件
類似銘柄と比較する
現在ご覧いただいている「ラクオリア」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ラクオリア | 46,200円 | +138.6% | - | 0.00% | 42.35倍 | 1.78倍 |
|
ファイザー旧国内研究所が前身。導出した発売済み消化器薬等収益柱に成長、低分子創薬に強い |
ソレイジア | 5,000円 | +102.6% | - | 0.00% | - | 5.54倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
ペルセウス | 72,300円 | 0.0% | - | 0.00% | - | 6.06倍 |
|
東大発バイオベンチャー。高機能抗体の取得に強み。抗体医薬品や抗体薬物複合体(ADC)開発 |
モダリス | 14,100円 | - | - | 0.00% | - | 8.93倍 |
|
遺伝子治療薬の創薬ベンチャー、切断しない独自のゲノム編集技術に強み。研究開発中心は米国 |
仁 丹 | 211,400円 | +2.4% | +10.4% | 2.60% | 12.36倍 | 0.69倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
市場注目の銘柄
チャート関連のコラム